LGNZZ

Ligand Pharmaceuticals (PK) (LGNZZ)

Ligand Pharmaceuticals Incorporated (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:LGNZZ

1 2 3 4 5 6 7 8 9 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/19	10 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/06/19	10 : 27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/06/19	10 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/06/19	10 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/06/19	10 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/06/19	10 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/06/19	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/06/18	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/14	07 : 14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/14	06 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/10	07 : 06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/10	07 : 03	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/09	05 : 07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/08	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2024/05/07	20 : 36	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/06/06	05 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/05/09	05 : 29	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/05/07	05 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	08 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	08 : 24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	08 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	05 : 10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/25	05 : 07	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/08	05 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/07	06 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/04/03	05 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/03/14	07 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/28	07 : 38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/19	07 : 12	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)
2020/02/19	07 : 10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:LGNZZ	Ligand Pharmaceuticals Incorporated (PK)